USB
53
2
ECL
55
-4
PHM
54
-4
ROK
40
2
MCHP
39
5
MCO
71
-2
NDAQ
57
-2
RL
70
2
COST
57
4
EQIX
62
3
DE
68
8
RIG
40
-3
OXY
41
-3
COF
52
3
APD
67
2
BEN
30
2
SCHW
61
5
QRVO
51
15
GE
70
2
SPG
45
2
USB
53
2
ECL
55
-4
PHM
54
-4
ROK
40
2
MCHP
39
5
MCO
71
-2
NDAQ
57
-2
RL
70
2
COST
57
4
EQIX
62
3
DE
68
8
RIG
40
-3
OXY
41
-3
COF
52
3
APD
67
2
BEN
30
2
SCHW
61
5
QRVO
51
15
GE
70
2
SPG
45
2
Financhill
Back

Caribou Biosciences 10K Form

Sell
23

CRBU
Caribou Biosciences

Last Price:
$1.53
Seasonality Move:
-30.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRBU News And Ratings

See the #1 stock for the next 7 days that we like better than CRBU

CRBU Financial Statistics

Sales & Book Value

Annual Sales: $34.5M
Cash Flow: $-33.3M
Price / Cash Flow: 0
Annual Sales: $3.11
Price / Book: 0.49

Profitability

EPS (TTM): -1.66000
Net Income (TTM): $-148.1M
Gross Margin: --
Return on Equity: -43.52%
Return on Assets: -36.78%

Caribou Biosciences Earnings Forecast

Key Caribou Biosciences Financial Ratios

  • The Research & Development expenses have been 325.07% of Revenue.
  • The Net Earning history of CRBU is -296.05% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Caribou Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CRBU
Website: cariboubio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 7.38
Quick Ratio: 7.18

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRBU Technical Analysis vs Fundamental Analysis

Sell
23
Caribou Biosciences (CRBU) is a Sell

Is Caribou Biosciences a Buy or a Sell?